Kronos Bio, Inc. Restructuring, Settlement and Impairment Provisions
Kronos Bio, Inc. reported Restructuring, Settlement and Impairment Provisions of $3.07 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-08.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RestructuringSettlementAndImpairmentProvisions · last filed 2025-05-08
- Kronos Bio, Inc. restructuring, settlement and impairment provisions for the quarter ending 2025-03-31 was $3.07M, a 76.01% decline year-over-year.
- Kronos Bio, Inc. restructuring, settlement and impairment provisions for the quarter ending 2024-12-31 was $16.09M, a 720.97% increase year-over-year.
- Kronos Bio, Inc. restructuring, settlement and impairment provisions for the quarter ending 2024-09-30 was $0.00.
- Kronos Bio, Inc. restructuring, settlement and impairment provisions for the quarter ending 2024-06-30 was $578.00K, a 80.18% decline year-over-year.
- Kronos Bio, Inc. restructuring, settlement and impairment provisions for fiscal 2024 was $29.45M, a 504.08% increase from fiscal 2023.
- Kronos Bio, Inc. restructuring, settlement and impairment provisions for fiscal 2023 was $4.88M.
| Period end | Restructuring, Settlement and Impairment Provisions 3 month | Restructuring, Settlement and Impairment Provisions 6 month | Restructuring, Settlement and Impairment Provisions 9 month | Restructuring, Settlement and Impairment Provisions 12 month |
|---|---|---|---|---|
| 2025-03-31 | $3.07M 10-Q · filed 2025-05-08 | $19.16M derived: sum of 2 quarters · filed 2025-05-08 | $19.16M derived: sum of 3 quarters · filed 2025-05-08 | $19.74M derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-12-31 | $16.09M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $16.09M derived: sum of 2 quarters · filed 2025-03-18 | $16.67M derived: sum of 3 quarters · filed 2025-03-18 | $29.45M 10-K · filed 2025-03-18 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-13 | $578.00K derived: sum of 2 quarters · filed 2024-11-13 | $13.36M 10-Q · filed 2024-11-13 | $15.32M derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-06-30 | $578.00K 10-Q · filed 2024-08-08 | $13.36M 10-Q · filed 2024-08-08 | $15.32M derived: sum of 3 quarters · filed 2025-05-08 | $15.32M derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-03-31 | $12.79M 10-Q · filed 2025-05-08 | $14.75M derived: sum of 2 quarters · filed 2025-05-08 | $14.75M derived: sum of 3 quarters · filed 2025-05-08 | $17.66M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $1.96M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $1.96M derived: sum of 2 quarters · filed 2025-03-18 | $4.88M derived: sum of 3 quarters · filed 2025-03-18 | $4.88M 10-K · filed 2025-03-18 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-13 | $2.92M derived: sum of 2 quarters · filed 2024-11-13 | $2.92M 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $2.92M 10-Q · filed 2024-08-08 | $2.92M 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-09 |